Residual Solvents in Nanomedicine and Lipid-Based Drug Delivery Systems: a Case Study to Better Understand Processes

Pharmaceutical Research
Amrita DikpatiNicolas Bertrand

Abstract

Complexities surrounding the manufacture and quality control of nanomedicines become increasingly apparent. This research article offers a case study to investigate how, at the laboratory scale, various stages of liposome and nanoparticle synthesis affect the amount of residual solvent found in the formulations. The objective is to bring insights on the reliability of each of these processes to provide final products which meet regulatory standards and facilitate identifying possible bottleneck early during the development process. The residual solvent at various stages of preparation and purification was measured by headspace gas chromatography. Liposomes were prepared by two different methods with and without solvent. Polymer nanoparticles prepared via nanoprecipitation and purified by ultrafiltration were studied. The effects of purification by size exclusion chromatography and dialysis were also investigated. The complete removal of residual solvent requires processes which go beyond usual preparation methods. This work might prove valuable as a reference for scientists of different fields to compare their own practices and streamline the translation of nanomedicines into efficacious and safe drug products.

References

Oct 15, 1978·Analytical Biochemistry·D W FryI D Goldman
Mar 4, 2000·Toxicology and Applied Pharmacology·A M Saillenfait, J P Sabaté
Jun 18, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·John HerbergerEric Westhaus
Feb 7, 2006·International Journal of Pharmaceutics·JingXia CuiWei Wang
Apr 20, 2006·International Journal of Pharmaceutics·Sarinnate KunastitchaiBernd W Müller
Nov 23, 2006·Advanced Drug Delivery Reviews·Wassim AbdelwahedHatem Fessi
Aug 11, 2007·Micron : the International Research and Review Journal for Microscopy·Jean-Christophe ColasHarjinder Singh
Dec 23, 2009·International Journal of Pharmaceutics·Aaron S MayoUday B Kompella
Nov 12, 2010·ACS Nano·Nicolas BertrandJean-Christophe Leroux
Jun 25, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Guillaume BastiatJean-Pierre Benoit
Jul 22, 2015·Nature Communications·Ferdinand BrandlRobert Langer
Jul 27, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Elise LepeltierPatrick Couvreur
Feb 13, 2016·Science Translational Medicine·Susan AshtonSimon T Barry
Nov 12, 2016·Methods in Molecular Biology·Nicolas BertrandJean-Christophe Leroux
Oct 2, 2019·Bioengineering & Translational Medicine·Aaron C Anselmo, Samir Mitragotri
May 15, 2020·International Journal of Pharmaceutics·Sherif I HamdallahSheng Qi

❮ Previous
Next ❯

Citations

Sep 10, 2020·Nanoscale·Iara Maíra de Oliveira VianaNicolas Bertrand
May 28, 2021·Nano Letters·Youcef Chakib HaceneNicolas Bertrand
Jun 17, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Ritu GuptaHuan Xie

❮ Previous
Next ❯

Methods Mentioned

BETA
dynamic light scattering
nanoprecipitation
size exclusion chromatography

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.